The 3rd International Symposium on Tuberculosis and Mycobacteria: a Multidisciplinary Approach (ISTM 2026) was held in Bangkok, Thailand, on February 2-4, 2026. The Symposium brought together approximately 120 experts from 24 countries. The Global strategy to end tuberculosis aims to reduce the incidence of tuberculosis by 90% by 2035.
The three-day Symposium program included 42 oral and 37 poster presentations covering a variety of topics: genomics, translational medicine in public health, molecular epidemiology, host-pathogen interactions, vaccines and therapeutics, and non-tuberculous mycobacteria. Dr. Anna Vyazovaya, leading researcher, Laboratory of Molecular Epidemiology and Evolutionary Genetics, and Dr. Grigory Sergeev, junior researcher in the laboratory, participated in the symposium.
Anna Vyazovaya presented a poster presentation titled "Overwhelming prevalence of the beijing genotype among pre-extensively drug-resistant mycobacterium tuberculosis strains in Western Siberia, Russia."
Grigory Sergeev's paper "Development of bedaquiline resistance in serial isolates of mycobacterium tuberculosis obtained during treatment of patients with multidrug-resistant/ultra-extensively drug-resistant tuberculosis" was recognized among the four best poster presentations.
Institute scientists also participated in the 10th The Asia Pacific region conference of the union on Tuberculosis and Lung Disease (APRC 2026), held February 4-7 in Bangkok, Thailand.
The APRC 2026 Conference is a major international conference dedicated to improving lung health and tuberculosis prevention, held every 2-3 years by the International Union Against Tuberculosis and Lung Disease. The conference attracted approximately 1,000 participants. The four-day conference program included plenary sessions, breakout sessions, lectures, and symposia.
The poster session included 158 poster presentations, including Anna Vyazovaya's paper, "Genomic and epidemiological study in western Siberia", and Grigory Sergeev's paper, "An increase in the proportion of mycobacterium tuberculosis isolates with intrinsic resistance to bedaquiline indicates the beginning of their spread in Russia".
